Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.
FDA IND clearance enables a phase 3 program evaluating TRIESENCE for postoperative ocular inflammation and pain following cataract surgery, aiming to broaden on-label use beyond current intraocular ...
My good friend, an internist, recently retired because, after 35 years of practice, he wanted more free time but could only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results